COVID-19’s Vaccine and Drug Innovators Chosen as Recipients of the Galien Foundation 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity

The Prix Galien Awards Committee announced today that six world-leading biopharma companies responsible for development of COVID-19 vaccines and therapeutics will jointly receive the 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity at the 15th annual Prix Galien USA Awards Ceremony, to be held on Thursday, October 28, at the American Museum of Natural History in New York City. Continue reading